Radnet, Inc. (RDNT): Stephen M Forthuber , Executive Vice President of Radnet, Inc. sold 20,000 shares on Sep 19, 2016. The Insider selling transaction was reported by the company on Sep 21, 2016 to the Securities and Exchange Commission. The shares were sold at $7.18 per share for a total value of $143,600.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 23, 2016, Jeffrey L Linden (Executive Vice President) sold 30,000 shares at $6.41 per share price.On Aug 12, 2016, Mark Stolper (Executive VP and CFO) sold 35,414 shares at $6.25 per share price.Also, On Mar 21, 2016, Stephen M Forthuber (Executive Vice President) sold 29,000 shares at $5.21 per share price.On Dec 16, 2015, Michael N Murdock (Executive Vice President) sold 72,861 shares at $6.10 per share price.
Shares of RadNet (RDNT) ended Tuesday, Sep 21, 2016 session in red amid volatile trading. The shares closed down -0.12 points or -1.67% at $7.08 with 52,700 shares getting traded. Post opening the session at $7.25, the shares hit an intraday low of $7 and an intraday high of $7.25 and the price vacillated in this range throughout the day. The company has a market cap of $329 M and the number of outstanding shares has been calculated to be 4,64,32,404 shares. The 52-week high of RadNet is $7.5 and the 52-week low is $4.66.
RadNet Inc. is engaged in providing freestanding fixed-site outpatient diagnostic imaging services in the United States. The Company has a network of around 293 owned and/or operated outpatient imaging centers including around 74 facilities in the greater New York Metropolitan area. Its core markets include California Maryland Delaware New Jersey New York and Rhode Island. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI) computed tomography (CT) positron emission tomography (PET) nuclear medicine mammography ultrasound diagnostic radiology (X-ray) fluoroscopy and other related procedures. The Company has around 213 MRI systems 125 CT systems 44 PET or combination PET/CT systems 274 X-ray systems 392 ultrasound systems 44 nuclear medicine systems 226 mammography systems and 168 fluoroscopy systems in operation.